Herbistry420
hybrid

Ibs B342

Myrcene-dominant
THC
20.0–27.1%
CBD
0.0–0.1%
Dominant Terpene
Myrcene

About

Ibs B342 is a hybrid cannabis strain. Lab samples test between 20.0% and 27.1% THC, with myrcene (0.80%) as the dominant terpene.

Why does Ibs B342 have these effects?

Ibs B342's effects are driven by its dominant myrcene (0.80%), which has sedative and muscle-relaxant properties, combined with caryophyllene (0.63%), one of the few terpenes that binds directly to CB2 cannabinoid receptors.

Strain Profile

Energy
CalmingEnergizing
Potency
Low THCHigh THC

May Help With

Inflammation100%

Caryophyllene has strong anti-inflammatory properties

Pain77%

Myrcene has analgesic and muscle-relaxant properties

Stress66%

Linalool has calming, stress-relieving properties

Anxiety59%

Linalool is known for anti-anxiety effects

Based on terpene research and reported effects. Not medical advice. Consult a healthcare professional for medical decisions.

Similar Strains

Strains with a similar profile you might enjoy

Quick Info

Type
hybrid
Breeder
Not verified
THC
20.0–27.1%
CBD
0.1%
Chemotype
Myrcene-dominant

What is Myrcene?

The most common cannabis terpene, also found in mangoes, hops, and lemongrass.

Learn more →

Share

Share
← Back to all strains

About Ibs B342

Is Ibs B342 indica or sativa?
Ibs B342 is a hybrid cannabis strain. Hybrids combine characteristics of both indica and sativa genetics.
What is the THC content of Ibs B342?
Ibs B342 typically tests at 20.0% to 27.1% THC. This is considered a high-potency strain, so start with a low dose if you are new to it.
What terpenes are in Ibs B342?
The dominant terpenes in Ibs B342 are Myrcene, Caryophyllene, Limonene. Terpenes influence the aroma, flavor, and effects of a cannabis strain.